Is Concord Medical Stock a Good Investment?
Concord Medical Investment Advice | CCM |
- Examine Concord Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Concord Medical's leadership team and their track record. Good management can help Concord Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Concord Medical's business and its evolving consumer preferences.
- Compare Concord Medical's performance and market position to its competitors. Analyze how Concord Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Concord Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Concord Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Concord Medical Services stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Concord Medical Services is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Concord Medical Stock
Researching Concord Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 9.82. Concord Medical Services last dividend was issued on the 23rd of December 2015. The entity had 1:10 split on the 30th of July 2024.
To determine if Concord Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Concord Medical's research are outlined below:
| Concord Medical generated a negative expected return over the last 90 days | |
| Concord Medical has high historical volatility and very poor performance | |
| Concord Medical has high likelihood to experience some financial distress in the next 2 years | |
| Concord Medical Services has 3.93 B in debt with debt to equity (D/E) ratio of 1.25, which is OK given its current industry classification. Concord Medical Services has a current ratio of 0.7, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Concord to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 383.96 M. Reported Net Loss for the year was (652.08 M) with loss before taxes, overhead, and interest of (79.16 M). | |
| Concord Medical Services has about 157.39 M in cash with (397.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72. | |
| Concord Medical has a frail financial position based on the latest SEC disclosures | |
| Roughly 18.0% of Concord Medical shares are held by company insiders | |
| Latest headline from forbes.com: Proposed Changes To Phone Services For Social Security Beneficiaries Raise ConcernsAgain |
Concord Medical Quarterly Liabilities And Stockholders Equity |
|
Concord Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Concord Medical Services. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Concord Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 17th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Concord Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Concord Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2014-03-31 | 2013-12-31 | 0.06 | 0.05 | -0.01 | 16 | ||
2010-08-18 | 2010-06-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2010-05-27 | 2010-03-31 | 0.07 | 0.06 | -0.01 | 14 | ||
2011-08-16 | 2011-06-30 | 0.1 | 0.12 | 0.02 | 20 | ||
2011-05-18 | 2011-03-31 | 0.09 | 0.07 | -0.02 | 22 | ||
2015-03-23 | 2014-12-31 | 0.13 | 0.1 | -0.03 | 23 | ||
2014-08-13 | 2014-06-30 | 0.1 | 0.13 | 0.03 | 30 | ||
2010-03-18 | 2009-12-31 | 0.14 | 0.11 | -0.03 | 21 |
Know Concord Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Concord Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Concord Medical Services backward and forwards among themselves. Concord Medical's institutional investor refers to the entity that pools money to purchase Concord Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Rhumbline Advisers | 2025-03-31 | 295 | Ubs Group Ag | 2025-03-31 | 217 | Sbi Securities Co Ltd | 2025-03-31 | 4.0 |
Concord Medical's market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 26.05 M.Market Cap |
|
Concord Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | (0.12) | (0.11) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | 0.14 | 0.14 |
Determining Concord Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Concord Medical is a good buy. For example, gross profit margin measures Concord Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Concord Medical's profitability and make more informed investment decisions.
Evaluate Concord Medical's management efficiency
Concord Medical Services has Return on Asset of (0.0521) % which means that on every $100 spent on assets, it lost $0.0521. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3876) %, meaning that it generated no profit with money invested by stockholders. Concord Medical's management efficiency ratios could be used to measure how well Concord Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 5th of August 2025, Return On Equity is likely to grow to 0.14, while Return On Tangible Assets are likely to drop (0.06). As of the 5th of August 2025, Debt To Assets is likely to grow to 0.61, while Total Assets are likely to drop about 4.2 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 370.36 | 359.98 | |
| Tangible Book Value Per Share | 83.60 | 79.42 | |
| Enterprise Value Over EBITDA | (11.24) | (10.68) | |
| Enterprise Value Multiple | (10.76) | (10.23) | |
| Enterprise Value | 3.9 B | 3.7 B |
Concord Medical showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Beta (0.94) |
Basic technical analysis of Concord Stock
As of the 5th of August, Concord Medical shows the Risk Adjusted Performance of (0.02), mean deviation of 3.96, and Standard Deviation of 5.81. Concord Medical Services technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Concord Medical Services variance and value at risk to decide if Concord Medical Services is priced correctly, providing market reflects its regular price of 5.34 per share. Given that Concord Medical has information ratio of (0.06), we suggest you to validate Concord Medical Services's prevailing market performance to make sure the company can sustain itself at a future point.Concord Medical's Outstanding Corporate Bonds
Concord Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Concord Medical Services uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Concord bonds can be classified according to their maturity, which is the date when Concord Medical Services has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Concord Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Concord Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.27) | |||
| Mean Deviation | 3.96 | |||
| Coefficient Of Variation | (2,437) | |||
| Standard Deviation | 5.81 | |||
| Variance | 33.75 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (1.01) | |||
| Treynor Ratio | (0.28) | |||
| Maximum Drawdown | 28.15 | |||
| Value At Risk | (10.74) | |||
| Potential Upside | 8.41 | |||
| Skewness | 0.0057 | |||
| Kurtosis | 3.1 |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.27) | |||
| Mean Deviation | 3.96 | |||
| Coefficient Of Variation | (2,437) | |||
| Standard Deviation | 5.81 | |||
| Variance | 33.75 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (1.01) | |||
| Treynor Ratio | (0.28) | |||
| Maximum Drawdown | 28.15 | |||
| Value At Risk | (10.74) | |||
| Potential Upside | 8.41 | |||
| Skewness | 0.0057 | |||
| Kurtosis | 3.1 |
Consider Concord Medical's intraday indicators
Concord Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Concord Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Concord Medical Corporate Filings
6K | 29th of July 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 25th of April 2025 Other Reports | ViewVerify |
Concord Stock media impact
There is far too much social signal, news, headlines, and media speculation about Concord Medical that are available to investors today. This information is accessible both publicly - through Concord Medical's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Concord-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Concord Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Concord Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Concord Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Concord Medical alpha.
Concord Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Concord Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Concord Medical Corporate Management
| Xun Liu | Financial Controller | Profile | |
| Matthew Callister | Chief Medical Officer | Profile | |
| Boxun Zhang | Independent Director | Profile | |
| Yue Yu | Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.82) | Revenue Per Share | Quarterly Revenue Growth (0.35) | Return On Assets | Return On Equity |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Concord Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.